Entourage Health Corp. (ENTG.V)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2023 | -46.16 Million CAD | 62.51% |
| 2022 | -123.14 Million CAD | -56.01% |
| 2021 | -78.93 Million CAD | 11.91% |
| 2020 | -89.6 Million CAD | -762.24% |
| 2019 | -10.39 Million CAD | -1060.99% |
| 2018 | -895.12 Thousand CAD | 89.83% |
| 2017 | -8.8 Million CAD | -8848.21% |
| 2016 | -98.4 Thousand CAD | -200.2% |
| 2015 | -32.77 Thousand CAD | 74.94% |
| 2014 | -130.82 Thousand CAD | 0.0% |
| Year | Net Income | Net Income Growth |
|---|---|---|
| 2024 Q2 | -10.32 Million CAD | -64.09% |
| 2024 Q1 | -6.29 Million CAD | 63.36% |
| 2023 FY | -46.16 Million CAD | 62.51% |
| 2023 Q1 | -9.54 Million CAD | 89.14% |
| 2023 Q4 | -17.17 Million CAD | -73.4% |
| 2023 Q2 | -9.57 Million CAD | -0.29% |
| 2023 Q3 | -9.9 Million CAD | -3.48% |
| 2022 Q2 | -9.02 Million CAD | -3.01% |
| 2022 Q3 | -17.43 Million CAD | -93.1% |
| 2022 FY | -123.14 Million CAD | -56.01% |
| 2022 Q1 | -8.76 Million CAD | 80.31% |
| 2022 Q4 | -87.92 Million CAD | -404.37% |
| 2021 FY | -78.93 Million CAD | 11.91% |
| 2021 Q3 | -17.46 Million CAD | -75.53% |
| 2021 Q4 | -44.5 Million CAD | -154.82% |
| 2021 Q2 | -9.95 Million CAD | -41.99% |
| 2021 Q1 | -7 Million CAD | 91.28% |
| 2020 Q3 | 8.63 Million CAD | 197.07% |
| 2020 Q4 | -80.34 Million CAD | -1030.5% |
| 2020 Q1 | -9 Million CAD | -24.84% |
| 2020 Q2 | -8.89 Million CAD | 1.19% |
| 2020 FY | -89.6 Million CAD | -762.24% |
| 2019 Q3 | -13.4 Million CAD | -206.16% |
| 2019 Q1 | -2.4 Million CAD | 68.84% |
| 2019 Q2 | 12.62 Million CAD | 625.18% |
| 2019 Q4 | -7.21 Million CAD | 46.2% |
| 2019 FY | -10.39 Million CAD | -1060.99% |
| 2018 Q2 | -1.76 Million CAD | -33.41% |
| 2018 FY | -895.12 Thousand CAD | 89.83% |
| 2018 Q4 | -7.71 Million CAD | -177.9% |
| 2018 Q3 | 9.9 Million CAD | 661.8% |
| 2018 Q1 | -1.32 Million CAD | 42.42% |
| 2017 Q2 | -4.75 Million CAD | -299.16% |
| 2017 FY | -8.8 Million CAD | -8848.21% |
| 2017 Q4 | -2.29 Million CAD | -311.45% |
| 2017 Q1 | -1.19 Million CAD | -1970.95% |
| 2017 Q3 | -557.8 Thousand CAD | 88.28% |
| 2016 Q1 | -6081.00 CAD | 72.98% |
| 2016 Q4 | -57.58 Thousand CAD | -444.66% |
| 2016 Q3 | -10.57 Thousand CAD | 56.26% |
| 2016 Q2 | -24.16 Thousand CAD | -297.43% |
| 2016 FY | -98.4 Thousand CAD | -200.2% |
| 2015 Q3 | -616.00 CAD | 81.9% |
| 2015 FY | -32.77 Thousand CAD | 74.94% |
| 2015 Q2 | -3403.00 CAD | 45.56% |
| 2015 Q1 | -6251.00 CAD | 94.24% |
| 2015 Q4 | -22.5 Thousand CAD | -3554.06% |
| 2014 Q3 | -22.24 Thousand CAD | 0.0% |
| 2014 FY | -130.82 Thousand CAD | 0.0% |
| 2014 Q4 | -108.57 Thousand CAD | -388.09% |
| Name | Net Income | Net Income Difference |
|---|---|---|
| Aequus Pharmaceuticals Inc. | -2.96 Million CAD | -1457.246% |
| CanadaBis Capital Inc. | 4.44 Million CAD | 1138.769% |
| Decibel Cannabis Company Inc. | -1.77 Million CAD | -2508.362% |
| Delivra Health Brands Inc. | 876 Thousand CAD | 5370.321% |
| Lifeist Wellness Inc. | -14.12 Million CAD | -226.838% |
| Cannara Biotech Inc. | 6.94 Million CAD | 764.726% |
| Medicure Inc. | -922 Thousand CAD | -4907.376% |
| PharmaCielo Ltd. | -16.29 Million CAD | -183.28% |
| Rubicon Organics Inc. | -1.82 Million CAD | -2431.785% |
| BioSyent Inc. | 6.46 Million CAD | 814.661% |
| Voyageur Pharmaceuticals Ltd. | -1.39 Million CAD | -3198.966% |